Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-05

Clinical Trial Update: SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

View source ↗

Summary

The STAR Registry, a registry for systemic sclerosis (scleroderma) sponsored by NIAID, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Scleroderma, Systemic, Sclerosis | Status: COMPLETED